UBE Corporation
Notice of Revision to Earnings Forecast
Revisions to interim and full-year earnings forecasts. Interim net sales up +4.1% from previous forecast, operating income up +12.8%, ordinary income up +4.0%, net income attributable to owners of parent for the interim up +10.5%. Full-year net sales up +6.8%, operating income up +12.8%, ordinary income up +4.0%, net income up +4.1%. Dividend forecast unchanged.
Key Figures
- Net Sales: 244,700 million yen (interim)
- Operating Income: 12,200 million yen (interim)
- Net Income Attributable to Owners of Parent: 10,500 million yen (interim)
AI要約
Revision of Forecasts and Background
This document revises the interim and full-year earnings forecasts announced on May 13, 2026. Interim net sales are expected to exceed the previous forecast due to sales price increases driven by rising raw material and fuel costs in the Resins & Chemicals segment, and operating income, ordinary income and interim net income are also expected to increase. For the full consolidated fiscal year, solid sales are expected across multiple segments led by Resins & Chemicals, resulting in projections above the previous forecast. The dividend forecast remains unchanged.
Outlook and Segmental Impact
The full-year forecast for the fiscal year ending March 2027 raises net sales driven by price increases in the Resins & Chemicals segment; although integration costs in the Functional Products & Machinery segment will increase, the overall view is above the previous forecast. Weak sales in the Pharmaceuticals segment will have an impact, but overall profit levels are expected to improve. Specific figures depend on the latest revised forecasts.
UBE Corporation
Company overview · Stock price · Financial data · All IR
